[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-366687-105":59,"doc-detail-366687-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","circrna-14052-promotes-breast-cancer-progression-via-mir-214-3pikbkb-pathway","CircRNA-14052 promotes breast cancer progression via miR-214-3p/IKBKB pathway","","This study investigates the regulatory mechanism of circRNA-14052 in breast cancer progression, focusing on its interaction with miR-214-3p and downstream activation of the IKBKB pathway. circRNA-14052 is upregulated while miR-214-3p is reduced in breast cancer tissues. Functional assays show that circRNA-14052 knockdown or miR-214-3p overexpression suppresses MCF-7 proliferation and induces apoptosis. Mechanistically, circRNA-14052 increases IKBKB via competitive sponging of miR-214-3p. In vivo xenograft experiments further confirm reduced tumor growth through the miR-214-3p/IKBKB/IL-6/JAK2/STAT3 axis, suggesting an actionable therapeutic target.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/circrna-14052-promotes-breast-cancer-progression-via-mir-214-3pikbkb-pathway/366687/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/circrna-14052-promotes-breast-cancer-progression-via-mir-214-3pikbkb-pathway/366687.png","ImageObject",300,407,{"name":92,"@type":93},"Well Done","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-08","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"What was the main objective of this study on circRNA-14052?","Question",{"text":112,"@type":113},"To investigate how circRNA-14052 regulates breast cancer progression through the miR-214-3p/IKBKB pathway and related signaling events.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How do circRNA-14052 and miR-214-3p differ in breast cancer tissues?",{"text":117,"@type":113},"circRNA-14052 levels are notably elevated, while miR-214-3p levels are markedly reduced in breast cancer tissues compared with adjacent non-cancerous tissues.",{"name":119,"@type":110,"acceptedAnswer":120},"What experimental evidence supports the proposed ceRNA mechanism?",{"text":121,"@type":113},"Luciferase reporter assays validated the circRNA-14052–miR-214-3p ceRNA regulatory network, and functional rescue showed that miR-214-3p inhibition reverses growth effects of circRNA-14052 silencing.",{"name":123,"@type":110,"acceptedAnswer":124},"What signaling axis is implicated in circRNA-14052-driven tumor progression?",{"text":125,"@type":113},"The study links circRNA-14052 to activation of the IKBKB pathway and highlights downstream IL-6/JAK2/STAT3 changes, both in vitro and in xenograft tumor models.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},366687,1790198312,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":143,"language":144,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":67,"update_tm":148,"read_time":149,"preview_page_count":19,"preview_urls":150},5909892210082,"https://ap-avatar.wpscdn.com/avatar/56001069da27c9f41e8?x-image-process=image/resize,m_fixed,w_180,h_180&k=1789614185077863061","Li et al. Hereditas (2025) 162:202  \n[https://doi.org/10.1186/s41065-025-00566-6](https://doi.org/10.1186/s41065-025-00566-6)  \nHereditas  \nRESEARCH Open Access  \nCircRNA-14052 promotes breast cancer progression via miR-214-3p/IKBKB pathway  \nDonghai Li 1†, Zhiying Zhang 1†, Yan Cui2, Jiaxin Sun3, Wenyuan Wei 1, Shaofeng Yang 1 and Rui Zhang 1*  \nAbstract  \nObjectives Circular RNAs play crucial regulatory roles in the progression of human diseases. This study aimed to investigate the functional mechanism of circRNA-14,052 in breast cancer progression.  \nMethods The biological functions of circRNA-14,052 were assessed using CCK-8, wound healing, flow cytometry assays. The ceRNA regulatory network of circRNA-14,052-miR-214-3p- IKBKB was validated by luciferase reporter assay. Results The levels of circRNA-14,052 were notably elevated, but the levels of miR-214-3p were markedly reduced in breast cancer tissues compared to adjacent non-cancerous tissues. Downregulation of circRNA-14,052 or overexpression of miR-214-3p reduced MCF-7 cell proliferation and triggered cell apoptosis. Mechanically, circRNA-14,052 could elevate IKBKB levels via competitively sponging miR-214-3p. Notably, miR-214-3p inhibition reversed the growth-suppressive effects of circRNA-14,052 silencing. Additionally, circRNA-14,052 knockdown notably reduced IKBKB, IL-6, JAK2 and STAT3 levels in MCF-7 cells; whereas these changes were reversed by miR-214-3p deficiency. Furthermore, deficiency of circRNA-14,052 reduced xenograft tumor growth in vivo through targeting miR- 214-3p/IKBKB/IL-6/JAK2/STAT3 axis.  \nConclusion Collectively, our results showed that circRNA-14,052 promotes breast cancer progression via the miR- 214-3p/IKBKB axis. Targeting this molecular axis may represent a promising therapeutic strategy for breast cancer treatment.  \nKeywords Breast cancer, CircRNA, circRNA-14052, miR-214-3p, IKBKB, JAK2-STAT3  \n†Donghai Li and Zhiying Zhang contributed equally to this work.  \n*Correspondence: Rui Zhang [zhangrui999999@163.com](zhangrui999999@163.com)  \n1Department of Thyroid Breast Surgery, Affiliated Hospital of Inner Mongolia Medical University, Hohhot North Street, Hohhot 010050, Inner Mongolia, China  \n2School of Humanities Education, Inner Mongolia Medical University, Huhhot 010000, Inner Mongolia, China  \n3Clinical Medical Research Center, Affiliated Hospital of Inner Mongolia Medical University, Hohhot North Street, Hohhot 010050, Inner Mongolia, China  \nIntroduction  \nBreast cancer has become one of the most frequent malignant diseases among global women [1]. It can be classified into four major molecular subtypes: Luminal A, Luminal B, HER2-enriched breast cancer, and triple-negative breast cancer (TNBC) [2]. Despite significant progress in standardized treatment, 30%-40% of early breast cancer patients eventually develop metastasis [1]. Given its substantial impact on public health, understanding the molecular mechanisms underlying breast cancer pathogenesis remains crucial. Thus, we tried to explore the molecular mechanism and found new molecular targets for the treatment and prognosis of breast cancer.  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org","cbCainDBvPpUrjk1","https://ap.wps.com/l/cbCainDBvPpUrjk1","pdf",3771156,14,"English","# Abstract\n## Objectives\n## Methods\n## Results\n## Conclusion\n# Introduction\n## Breast cancer background\n## Rationale for investigating circRNA-14052","[{\"question\":\"What was the main objective of this study on circRNA-14052?\",\"answer\":\"To investigate how circRNA-14052 regulates breast cancer progression through the miR-214-3p/IKBKB pathway and related signaling events.\"},{\"question\":\"How do circRNA-14052 and miR-214-3p differ in breast cancer tissues?\",\"answer\":\"circRNA-14052 levels are notably elevated, while miR-214-3p levels are markedly reduced in breast cancer tissues compared with adjacent non-cancerous tissues.\"},{\"question\":\"What experimental evidence supports the proposed ceRNA mechanism?\",\"answer\":\"Luciferase reporter assays validated the circRNA-14052–miR-214-3p ceRNA regulatory network, and functional rescue showed that miR-214-3p inhibition reverses growth effects of circRNA-14052 silencing.\"},{\"question\":\"What signaling axis is implicated in circRNA-14052-driven tumor progression?\",\"answer\":\"The study links circRNA-14052 to activation of the IKBKB pathway and highlights downstream IL-6/JAK2/STAT3 changes, both in vitro and in xenograft tumor models.\"}]","CircRNA-14052 promotes breast cancer progression via miR-214-3p/IKBKB pathway | PDF",1790166734,35,[151,155,159,163],{"page_no":8,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e36b40beb1e2ee6a3811bd690ddf80c4.webp",983,1310,{"page_no":14,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7506e0450619630f69f3335bab06c6a9.webp",982,1309,{"page_no":81,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cbab5c213f5e2a2c88c21d9575160b6a.webp",981,1308,{"page_no":19,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6dc855ed77e58a2c0a2c02df34e6ab2a.webp",980,1306]